Evidence map›Paper›PMID 42137623›Full record

ArticleFrontiers in bioengineering and biotechnology2026

Optimization and comparison of different methods for assessing cell viability in intervertebral disc organ cultures.

Marcia Muerner, Junxuan Ma, Barbora Kubincova, Christoph M Sprecher, Martin J Stoddart, Sibylle Grad

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marcia MuernerAO Research Institute Davos, Davos, Switzerland.
Junxuan MaAO Research Institute Davos, Davos, Switzerland.
Barbora KubincovaAO Research Institute Davos, Davos, Switzerland.
Christoph M SprecherAO Research Institute Davos, Davos, Switzerland.
Martin J StoddartAO Research Institute Davos, Davos, Switzerland.
Sibylle GradAO Research Institute Davos, Davos, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Whole-organ intervertebral disc (IVD) culture is widely used to study IVD degeneration and evaluate regenerative therapies. Spatial visualization of resident cell viability is essential, yet commonly used assays, such as Calcein AM/Ethidium Homodimer-1 (EthD-1), lactate dehydrogenase (LDH)/EthD-1, and MTT/DAPI, lack standardized protocols that facilitate implementation. Methods: In this study, we optimized and compared protocols for all three staining methods in bovine caudal IVDs and evaluated their strengths and limitations using appropriate positive and negative controls. Results: Selection of suitable controls was critical for reliable viability assessment. Calcein AM/EthD-1 provided a straightforward approach but required protocol modifications, including Collagenase P pre-treatment, to ensure adequate tissue penetration. This method also requires immediate processing and imaging after harvesting. In contrast, LDH/EthD-1 and MTT/DAPI allows for less time-sensitive workflows and enables repeated staining. However, LDH/EthD-1 is unsuitable for short-term experiments, as LDH signal persists for up to 36 h after cell death, except under extreme conditions such as repeated snap-freezing. MTT/DAPI proved more suitable for short-term applications. Discussion: These findings provide practical guidance for selecting and implementing viability assays in IVD culture, facilitating method choice based on specific experimental objectives and time constraints. Moreover, the insights gained may also be applicable to other dense tissues, such as tendon and cartilage.

Indexed as

calcein AM/EthD-1cell viabilityintervertebral discLDH assayMTT assaytissue viability

Identifiers

PMID42137623
PMCPMC13167986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.